of the award-winning PrecisionMedicinePodcast.com

Clinical conversations about the effective use of precision medicine for cancer care.

Spotify_Logo_RGB_Black.png
en_badge_web_music.png
Stitcher_Listen_Badge_Color_Light_BG.png
apple_podcasts.png
TwitterIcon_Bird_Only2.png
Welcome to Season 2!

Get the latest episode straight to your in-box.

Archive: Season 1
Season 2
EPISODE 30
Dr. John Quackenbush: Using Massive Data to Approach Precision Medicine Beyond Simple Mutations

In this first episode of season two, Dr. John Quackenbush discusses his approach to understanding what makes cancer cancer by studying entire gene networks rather than simple mutations. Dr. Quackenbush is Chair of the Department of Biostatistics at Harvard University's T.H. Chan School of Public Health and one of the first people to have worked on the Human Genome Project.

Listen here

Airdate: 01.09.20   |   Length: 24:10

EPISODE 29
Dr. Selin Kurnaz of Massive Bio Explains the Need to Operationalize Patient Support in Precision Cancer Care

Dr. Selin Kurnaz, CEO and cofounder of Massive Bio talks with us about the importance of increasing patient accessibility to clinical trials, FDA changes that affect clinical trial matching and the challenge of harmonizing disparate healthcare data for better patient careListen here

Airdate: 12.19.19   |   Length: 11:52

EPISODE 28
YouScript CEO Kristine Ashcraft on Advancing Precision Medicine by Breaking Down Information Silos

In this episode, we talk with Kristine Ashcraft, founder and CEO of YouScript, a platform that synthesizes all evidence impacting drug response, including pharmacogenetic testing, to support doctors and pharmacists in making faster, more proactive decisions at the point of care. Listen here

Airdate: 11.21.19   |   Length: 22:30

EPISODE 27
Expanding the Reach of Precision Medicine: Dr. Bruce Johnson former ASCO President and DFCI Leader Shares His Platform

Dr. Bruce Johnson, Chief Clinical Research Officer from the Dana Farber Cancer Institute, joins us to discuss how recent advances in treating rare cancers can help drive the understanding and expansion of precision medicine. Listen here

Airdate: 11.08.19   |   Length: 24:26

EPISODE 26
Can Precision Medicine Be a Win-Win for All Stakeholders? Dr. Edward Abrahams of The PMC Believes It’s Possible

Dr. Edward Abrahams is President of the Personalized Medicine Coalition (PMC). Here, we discuss the evolution of precision medicine and the value it can bring to all stakeholders, including innovators, scientists, patients, providers, and payers. Listen here

Airdate: 10.25.19   |   Length: 20:49

EPISODE 25
Dr. Erica Stringer-Reasor Shares Her Expertise on Precision Medicine Advancements in Breast Cancer 

In honor of breast cancer awareness month, Dr. Erica Stringer-Reasor joins us to discuss how breast cancer has led the way in the adoption of precision medicine. Dr. Stringer-Reasor is an expert in the field of breast cancer, a fast-rising star in cancer research and Assistant Professor of Hematology Oncology at the University of Alabama, Birmingham. Listen here

Airdate: 10.09.19   |   Length: 18.21

Archive: Season 1

How can we resolve the complexities of using precision medicine for cancer care?

Trapelo knows.

PHONE  617.250.7572

FAX  888.972.5991

EMAIL info@interventioninsights.com

800 District Ave, Suite 310
Burlington, MA 01803

Google Map »

icon-linkedin.png
TwitterIcon_Bird_Only2.png
YouTube_Icon_Only_Orange_Trans.png

Copyright 2019 Intervention Insights. All rights reserved. Privacy Policy